Date Range
Date Range
Date Range
We have updated our Privacy Policy to disclose that we do not respond to Do Not Track signals in browsers and that we do not collect Personally Identifiable Information from you to monitor your online activities across third party websites or online services. For full details of our Do Not Track policy, please see our Privacy Policy. AMD is the most common cause of irreversible vision loss in the developed world, the overwhelming majority of which is associated with the dry form of the disease.
Afidro - Asociacion de laboratorios de investigacion y desarrollo. Asociación de Laboratorios Farmacéuticos de Investigación y Desarrollo. AFIDRO lanzó su Código de Ética 2015. Al evento asistió el Gobierno, la industria en general, el cuerpo médico, pacientes, medios de comunicación, entre otros. Declaratoria de Emergencia en el plan de desarrollo? Lanzamiento del código de ética AFIDRO 2015. Puede ser de su interés.
企業ニーズ追加 持田製薬 株 オープンイノベーション ニーズ.
This website provides access to information from Astellas sponsored clinical trials and the purpose is not to promote or advertise any produ. CSR Activities in Five Fields.
And the safe use of juvenile products. Safe and Sound for Baby. Become a member of the only association solely dedicated to promoting the industry and the safe use and selection of juvenile products! Safety is the top priority of the baby products industry. See how you can demonstrate your commitment to making and selling safe products. JPMA Welcomes New Online Experience with Launch of jpma. You may have noticed that www.
O blog oficial do projeto Jogando Pelo Meio Ambiente. Impactos das mudanças climáticas sobre o desenvolvimento humano. Divulgado na última quarta-feira, dia 2 de Novembro, o ranking de desenvolvimento humano coloca o Brasil na 84ª posição. Mesmo com um grau de desenvolvimento humano considerado alto, o país se mantém atrás de vários países de expressão econômica muito menor, como Panamá, Malásia e Trinidad e Tobago. Relatório de Desenvolvimento Humano de 2011.